Rheumatology International

, Volume 34, Issue 6, pp 849–850 | Cite as

Antiphospholipid antibodies in children with Kawasaki disease: a preliminary study from North India

  • M. George
  • J. Ahluwalia
  • A Gupta
  • J. Masih
  • S. K. Bose
  • S. Singh
Letter to the Editor
First Online:
Received:
Accepted:
  • 98 Downloads

Keywords

Kawasaki Disease Activate Partial Thromboplastin Time Lupus Anticoagulant Polyarteritis Nodosa Henoch Schonlein Purpura 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Notes

Conflict of interest

None of the authors has any conflict of interest.

References

  1. 1.
    Sundel RP, Petty RE (2011) Kawasaki disease. In: Cassidy JT, Petty RE, Laxer RM, Lindsley C (eds) Textbook of pediatric rheumatology, 6th edn. Elseviers, Philadelphia, pp 505–520CrossRefGoogle Scholar
  2. 2.
    Sangle NA, Smock KJ (2011) Antiphospholipid antibody syndrome. Arch Pathol Lab Med 135:1092–1096PubMedCrossRefGoogle Scholar
  3. 3.
    Devreese KMJ (2012) Standardization of antiphospholipid antibody assays. Where do we stand? Lupus 21:718–721PubMedCrossRefGoogle Scholar
  4. 4.
    Gedalia A, Molina JF, García CO, Doggett S, Espinoza LR, Gharavi AE (1998) Anticardiolipin antibodies in childhood rheumatic disorders. Lupus 7:551–553PubMedCrossRefGoogle Scholar
  5. 5.
    Seaman DE, Londino AV Jr, Kwoh CK, Medsger TA Jr, Manzi S (1995) Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 96:1040–1045PubMedGoogle Scholar
  6. 6.
    Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ, Chiang BL (2000) Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura. Clin Exp Immunol 122:285–290PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Hansen KE, Moore KD, Ortel TL, Allen NB (1999) Antiphospholipid antibodies in patients with Wegener’s granulomatosis and polyarteritis nodosa. Arthritis Rheum 42:2250–2252PubMedCrossRefGoogle Scholar
  8. 8.
    Vaarala O, Salo E, Pelkonen P, Palosuo T, Aho K (1990) Anticardiolipin response in Kawasaki disease. Acta Paediatr Scand 79:804–809PubMedCrossRefGoogle Scholar
  9. 9.
    Falcini F, Trapani S, Turchini S, Farsi A, Ermini M, Keser G et al (1997) Immunological findings in Kawasaki disease: an evaluation in a cohort of Italian children. Clin Exp Rheumatol 15:685–689PubMedGoogle Scholar
  10. 10.
    Gupta M, Johann-Liang R, Bussel JB, Gersony WM, Lehman TJ (2002) Elevated IgA and IgM anticardiolipin antibodies in acute Kawasaki disease. Cardiology 97:180–182PubMedCrossRefGoogle Scholar
  11. 11.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young American heart association. Pediatrics 114:1708–1733PubMedCrossRefGoogle Scholar
  12. 12.
    Ahluwalia J, Singh S, Garewal G (2005) Antiphospholipid antibodies in children with systemic lupus erythematosus. Rheumatol Int 25(7):530–535PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • M. George
    • 1
  • J. Ahluwalia
    • 1
  • A Gupta
    • 1
  • J. Masih
    • 1
  • S. K. Bose
    • 1
  • S. Singh
    • 1
  1. 1.Pediatric Allergy Immunology Unit, Advanced Pediatrics CentrePostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations